179 related articles for article (PubMed ID: 2926180)
1. Hydralazine-induced enhancement of hyperthermic damage in a C3H mammary carcinoma in vivo.
Horsman MR; Christensen KL; Overgaard J
Int J Hyperthermia; 1989; 5(2):123-36. PubMed ID: 2926180
[TBL] [Abstract][Full Text] [Related]
2. Thermoradiotherapy with hydralazine: the effect of preirradiation of the tumor bed on blood flow and growth delay of Ehrlich carcinoma.
Kozin SV; Kozina LV
Radiat Res; 1999 Jan; 151(1):79-84. PubMed ID: 9973088
[TBL] [Abstract][Full Text] [Related]
3. Dose-dependent effects of hydralazine on microcirculatory function and hyperthermic response of murine FSall tumors.
Kalmus J; Okunieff P; Vaupel P
Cancer Res; 1990 Jan; 50(1):15-9. PubMed ID: 2293549
[TBL] [Abstract][Full Text] [Related]
4. Reduction of tumour blood flow by vasoactive drugs: a role in cancer therapy.
Chaplin DJ; Acker BD; Horsman MR
Biomed Biochim Acta; 1989; 48(2-3):S264-8. PubMed ID: 2730621
[TBL] [Abstract][Full Text] [Related]
5. Effects of magnetic fluid hyperthermia (MFH) on C3H mammary carcinoma in vivo.
Jordan A; Scholz R; Wust P; Fähling H; Krause J; Wlodarczyk W; Sander B; Vogl T; Felix R
Int J Hyperthermia; 1997; 13(6):587-605. PubMed ID: 9421741
[TBL] [Abstract][Full Text] [Related]
6. [Effect of hydralazine on the blood flow of normal and tumor tissues in hyperthermia].
Ohshima T; Tanaka Y
Nihon Igaku Hoshasen Gakkai Zasshi; 1993 Aug; 53(8):960-9. PubMed ID: 8371944
[TBL] [Abstract][Full Text] [Related]
7. Effects of hydralazine on the blood flow in RIF-1 tumors and normal tissues of mice.
Lin JC; Song CW
Radiat Res; 1990 Nov; 124(2):171-7. PubMed ID: 2247597
[TBL] [Abstract][Full Text] [Related]
8. Effect of nitro-L-arginine on blood flow, oxygenation and the activity of hypoxic cell cytotoxins in murine tumours.
Horsman MR; Chaplin DJ; Hill SA; Arnold S; Collingridge D; Radacic M; Wood PJ; Overgaard J
Br J Cancer Suppl; 1996 Jul; 27():S168-71. PubMed ID: 8763873
[TBL] [Abstract][Full Text] [Related]
9. Tumour-specific enhancement of thermoradiotherapy at mild temperatures by the vascular targeting agent 5,6-dimethylxanthenone-4-acetic acid.
Murata R; Horsman MR
Int J Hyperthermia; 2004 Jun; 20(4):393-404. PubMed ID: 15204520
[TBL] [Abstract][Full Text] [Related]
10. [Hydralazine-induced enhancement of hyperthermia treatment in vivo].
Oshima T; Akagi K; Hasegawa T; Tanaka Y
Nihon Igaku Hoshasen Gakkai Zasshi; 1992 Nov; 52(11):1582-8. PubMed ID: 1465339
[TBL] [Abstract][Full Text] [Related]
11. Combined adriamycin and hyperthermia treatment of a murine mammary carcinoma in vivo.
Overgaard J
Cancer Res; 1976 Sep; 36(9 pt.1):3077-81. PubMed ID: 975075
[TBL] [Abstract][Full Text] [Related]
12. Combination of nicotinamide and hyperthermia to eliminate radioresistant chronically and acutely hypoxic tumor cells.
Horsman MR; Chaplin DJ; Overgaard J
Cancer Res; 1990 Dec; 50(23):7430-6. PubMed ID: 2147577
[TBL] [Abstract][Full Text] [Related]
13. The new vascular disrupting agent combretastatin-A1-disodium-phosphate (OXi4503) enhances tumour response to mild hyperthermia and thermoradiosensitization.
Hokland SL; Horsman MR
Int J Hyperthermia; 2007 Nov; 23(7):599-606. PubMed ID: 18038290
[TBL] [Abstract][Full Text] [Related]
14. Development of thermotolerance during fractionated hyperthermia in a solid tumor in vivo.
Kamura T; Nielsen OS; Overgaard J; Andersen AH
Cancer Res; 1982 May; 42(5):1744-8. PubMed ID: 7066896
[TBL] [Abstract][Full Text] [Related]
15. Effects of RSR13 and oxygen on the cytotoxicity of cisplatin and carboplatin to EMT6 mouse mammary tumor cells in vitro and in vivo.
Donnelly ET; Kelley M; Rockwell S
Cancer Chemother Pharmacol; 2004 Jan; 53(1):43-50. PubMed ID: 14574460
[TBL] [Abstract][Full Text] [Related]
16. Enhanced local tumour control after single or fractionated radiation treatment using the hypoxic cell radiosensitizer doranidazole.
Murata R; Tsujitani M; Horsman MR
Radiother Oncol; 2008 Jun; 87(3):331-8. PubMed ID: 18375007
[TBL] [Abstract][Full Text] [Related]
17. Effects of hyperthermia on blood flow and cis-diamminedichloroplatinum(II) pharmacokinetics in murine mammary adenocarcinomas.
Ausmus PL; Wilke AV; Frazier DL
Cancer Res; 1992 Sep; 52(18):4965-8. PubMed ID: 1516052
[TBL] [Abstract][Full Text] [Related]
18. Simultaneous inhibition of the receptor kinase activity of vascular endothelial, fibroblast, and platelet-derived growth factors suppresses tumor growth and enhances tumor radiation response.
Griffin RJ; Williams BW; Wild R; Cherrington JM; Park H; Song CW
Cancer Res; 2002 Mar; 62(6):1702-6. PubMed ID: 11912143
[TBL] [Abstract][Full Text] [Related]
19. Relationship between heat-induced vascular damage and thermosensitivity in four mouse tumors.
Nishimura Y; Shibamoto Y; Jo S; Akuta K; Hiraoka M; Takahashi M; Abe M
Cancer Res; 1988 Dec; 48(24 Pt 1):7226-30. PubMed ID: 3191494
[TBL] [Abstract][Full Text] [Related]
20. The effects of vasodilating drugs on pH in tumors.
Adachi E; Tannock IF
Oncol Res; 1999; 11(4):179-85. PubMed ID: 10566616
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
